STOCK TITAN

Invesco Ltd. reports 4.96M-share stake in IVZ (Invesco Emerging Markets ETF)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Invesco Ltd. reports beneficial ownership of 4,957,814 shares of Invesco Emerging Markets Sovereign Debt ETF, representing 7.5% of the class as of 03/31/2026. The shares are held of record by clients of Invesco Ltd.; no single shareholder is reported to hold more than 5% economic ownership. The filing states sole voting and dispositive power over the 4,957,814 shares and identifies related advisory subsidiaries Invesco Advisers, Inc. and Invesco Investment Advisers LLC. The schedule is signed by Robert R. Leveille, Global Head of Compliance, on 05/06/2026.

Positive

  • None.

Negative

  • None.

Insights

Invesco Ltd. holds a meaningful passive stake in the ETF (7.5%).

The filing lists 4,957,814 shares beneficially owned as of 03/31/2026, with sole voting and dispositive power attributed to Invesco Ltd. The shares are record-held by client accounts, consistent with advisory control rather than direct corporate treasury holdings.

Key dependencies include client redemption/swap activity and portfolio mandates managed by the named advisory subsidiaries. Subsequent filings may disclose changes in percent ownership or voting arrangements.

Schedule 13G reporting reflects passive beneficial ownership and adviser reporting conventions.

The filing follows Schedule 13G structure: it identifies the reporting person, provides the 7.5% percent of class figure, and states voting/dispositive powers. It notes that no individual shareholder exceeds 5% economic ownership and references the Investment Company Act exemption for fund shareholder lists.

Material changes to monitor are any amendments that adjust the reported percent or disclose attribution to specific client accounts; the signature date is 05/06/2026.

Beneficial ownership 4,957,814 shares As of 03/31/2026
Percent of class 7.5% As reported in Item 4(b)
Sole voting power 4,957,814 shares Item 4(c)(i)
Sole dispositive power 4,957,814 shares Item 4(c)(iii)
Signature date 05/06/2026 Schedule signed by Robert R. Leveille
beneficially owned regulatory
"may be deemed to beneficially own 4,957,814 shares"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Sole Voting Power regulatory
"Sole Voting Power 4,957,814.00"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
Schedule 13G regulatory
"Item 1. (a) Name of issuer: Invesco Emerging Markets Sovereign Debt ETF"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
Investment Company Act of 1940 regulatory
"listing of the shareholders of an investment company registered under the Investment Company Act of 1940"
A U.S. federal law that sets the rulebook for pooled investment vehicles such as mutual funds, exchange-traded funds and similar money managers, requiring them to register with regulators, disclose holdings and fees, limit conflicts of interest, and follow governance standards. It matters to investors because these protections and transparency rules act like a referee and scoreboard, helping people compare funds, trust that managers follow fair practices, and spot hidden costs or risks.





46138E784

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G



Invesco Ltd.
Signature:Robert R. Leveille
Name/Title:Global Head of Compliance
Date:05/06/2026

FAQ

What stake does Invesco Ltd. report in Invesco Emerging Markets Sovereign Debt ETF (IVZ)?

Invesco Ltd. reports beneficial ownership of 4,957,814 shares, or 7.5% of the class as of 03/31/2026. The shares are held of record by client accounts advised by Invesco entities and reported under Schedule 13G.

Who holds voting and disposition authority for the shares reported by Invesco Ltd. (IVZ)?

The filing states Invesco Ltd. has sole voting and sole dispositive power over all 4,957,814 shares. The reported control reflects advisory authority over client-held fund shares, per the Schedule 13G disclosure.

Which subsidiaries are identified in the Invesco Ltd. Schedule 13G filing for IVZ?

The filing names Invesco Advisers, Inc. and Invesco Investment Advisers LLC as the advisory subsidiaries related to the reported position. These entities are noted in the Item 7 subsidiary identification section.

Does the Schedule 13G filing indicate any single shareholder with over 5% economic ownership of IVZ?

The filing states that no single individual shareholder holds greater than 5% economic ownership. It notes shareholder lists for registered investment companies are not required to be disclosed under the Investment Company Act.

What are the relevant dates on the Invesco Ltd. Schedule 13G for IVZ?

The beneficial ownership is reported as of 03/31/2026 and the Schedule 13G is signed by Robert R. Leveille on 05/06/2026. These dates anchor the reported position and the signature certification.